Wittes RE - Search Results

1

Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.

Wilson WH, Jain V, Bryant G, Cowan KH, Carter C, Cottler-Fox M, Goldspiel B, Steinberg SM, Longo DL, Wittes RE. Wilson WH, et al. Among authors: wittes re. J Clin Oncol. 1992 Nov;10(11):1712-22. doi: 10.1200/JCO.1992.10.11.1712. J Clin Oncol. 1992. PMID: 1403054 Clinical Trial.

2

Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.

Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, Wittes RE, DeVita VT Jr, Young RC. Longo DL, et al. Among authors: wittes re. J Clin Oncol. 1994 Oct;12(10):2153-9. doi: 10.1200/JCO.1994.12.10.2153. J Clin Oncol. 1994. PMID: 7523607 Clinical Trial.

3

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.

Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. Among authors: wittes re. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.

4

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. Among authors: wittes re. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.

5

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, et al. Wilson WH, et al. Among authors: wittes re. J Clin Oncol. 1993 Aug;11(8):1573-82. doi: 10.1200/JCO.1993.11.8.1573. J Clin Oncol. 1993. PMID: 7687667 Clinical Trial.

6

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shaughnessy J, et al. Wilson WH, et al. Among authors: wittes re. J Clin Oncol. 1994 Aug;12(8):1621-9. doi: 10.1200/JCO.1994.12.8.1621. J Clin Oncol. 1994. PMID: 7913721 Clinical Trial.

7

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.

Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT Jr. Longo DL, et al. Among authors: wittes re. J Clin Oncol. 1997 Nov;15(11):3338-46. doi: 10.1200/JCO.1997.15.11.3338. J Clin Oncol. 1997. PMID: 9363863 Clinical Trial.

8

Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant.

Little R, Wittes RE, Longo DL, Wilson WH. Little R, et al. Among authors: wittes re. J Clin Oncol. 1998 Feb;16(2):584-8. doi: 10.1200/JCO.1998.16.2.584. J Clin Oncol. 1998. PMID: 9469345

9

Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.

Urba WJ, Wilson WH, Duffey PL, Wittes R, Chabner BA, Longo DL. Urba WJ, et al. Semin Oncol. 1992 Dec;19(6 Suppl 13):26-32. Semin Oncol. 1992. PMID: 1283467 Review.

10

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.

Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Wilson WH, et al. Among authors: wittes re. Blood. 1996 Jun 1;87(11):4531-7. Blood. 1996. PMID: 8639820 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters